Security key
00461U105
Aclaris Therapeutics, Inc. - Common Stock, $0.00001 par value (ACRS)
CUSIP: 00461U105
Q3 2017 13F Holders as of 30 Sep 2017
- Security type / class
- Equity / Common Stock, $0.00001 par value
- Total 13F shares
- 28,502,689
- Total 13F value
- $696,914,157
- Share change
- +2,892,694
- Put/Call ratio
- 8.4%
- SEC-reported price per share
- $25.81
- Number of holders
- 102
- Value change
- +$73,632,695
- Number of buys
- 65
- Number of sells
- 36
- Shares outstanding
- 138,752,791
Holder snapshot
7 signals
Open additional details 1 more signal available
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q3 2017
Institutions
102
Top holders
10
ACRS full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q4 2017
Previous quarter: Q2 2017
Aclaris Therapeutics, Inc. SEC filings
Aclaris Therapeutics, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 00461U105
Recent filing periods:
Ownership snapshot
Top reported holders of ACRS - Aclaris Therapeutics, Inc. - Common Stock, $0.00001 par value (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Vivo Capital, LLC
Disclosed value leader
Vivo Capital, LLC
Comparable rows
15/15
Latest evidence
30 Jun 2017
13F
Lead comparable stake: 2.1%
Showing 1-6 of 15 holder rows.
Quick read
Vivo Capital, LLC leads the comparable SEC ownership view at 2.1%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Vivo Capital, LLC's linked filing trail.
Comparable ownership
Top 5
Vivo Capital, LLC
2.1%
FRANKLIN RESOURCES INC
1.4%
FMR LLC
1.4%
Sofinnova Management VIII, L.L.C.
1.1%
EAGLE ASSET MANAGEMENT INC
0.98%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Vivo Capital, LLC |
13F
Company
|
2.1%
|
$77,524,000
2,858,569 shares
|
— | 30 Jun 2017 |
| FRANKLIN RESOURCES INC |
13F
Company
|
1.4%
|
$53,030,000
1,955,381 shares
|
— | 30 Jun 2017 |
| FMR LLC |
13F
Company
|
1.4%
|
$51,425,000
1,896,206 shares
|
— | 30 Jun 2017 |
| Sofinnova Management VIII, L.L.C. |
13F
Company
|
1.1%
|
$41,751,000
1,539,480 shares
|
— | 30 Jun 2017 |
| EAGLE ASSET MANAGEMENT INC |
13F
Company
|
0.98%
|
$36,828,000
1,357,973 shares
|
— | 30 Jun 2017 |
| Polar Capital LLP |
13F
Company
|
0.97%
|
$36,505,000
1,346,049 shares
|
— | 30 Jun 2017 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q3 2017
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
102
Shares
28,502,689
Rows available
102
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q3 2017 vs Q2 2017 Across Filers
Q2 2017 holders
101
Q3 2017 holders
102
Holder diff
1
| Investor | Q2 2017 Shares | Q3 2017 Shares | Share Diff | Share Chg % | Q2 2017 value | Q3 2017 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend